Adjuvant Ipilimumab for Melanoma

We are all now used to hearing the broken record berating the high prices of cancer drugs. Usually such drugs cost in the region of $10 000 per month. While most expensive cancer drugs for solid tumors are used in the metastatic setting, there is currently only 1 modern immuno-oncologic agent approved in the adjuvant setting—ipilimumab for resected stage III melanoma. What is the benefit, cost, and value of this therapy?

from Cancer via ola Kala on Inoreader http://ift.tt/2zzST8z
via IFTTT